Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1995 Nov;69(11):6770–6778. doi: 10.1128/jvi.69.11.6770-6778.1995

Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations.

F Berrada 1, D Ma 1, J Michaud 1, G Doucet 1, L Giroux 1, A Kessous-Elbaz 1
PMCID: PMC189588  PMID: 7474088

Abstract

It is now well documented that human immunodeficiency virus type 1 (HIV-1) induces encephalopathy in patients with AIDS. In vitro studies have implicated the envelope protein (gp120) as a factor which causes neuronal death. To better evaluate the role and elucidate the mechanisms of gp120 neurotoxicity, we have developed transgenic mice carrying a segment of the HIV-1 genome that expresses the viral gp160 protein under the control of the human neurofilament light gene promoter. In two separate lines of transgenic mice, the Env protein was found to be expressed in several nuclei of the brain stem and in the anterior horns of the spinal cord. The two lines showed identical patterns of Env expression. Neuropathological evaluation revealed numerous abnormal dendritic swellings in the immunostained motor neuron structures. Large and numerous neuritic swellings were also prominent in the nucleus gracilis and in the gracilis and cuneate fascicles. In addition, reactive astrocytosis was observed in several immunoreactive areas of the central nervous system. These transgenic mice offer a unique model to further investigate the role of HIV-1 Env protein in neuronal toxicity and to help elucidate the mechanisms that are involved.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auffray C., Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980 Jun;107(2):303–314. doi: 10.1111/j.1432-1033.1980.tb06030.x. [DOI] [PubMed] [Google Scholar]
  2. Bird C., Gleeson P. A., Ramsay A., Li P., McCluskey J. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells. AIDS Res Hum Retroviruses. 1992 Dec;8(12):1999–2009. doi: 10.1089/aid.1992.8.1999. [DOI] [PubMed] [Google Scholar]
  3. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988 Oct 13;335(6191):639–642. doi: 10.1038/335639a0. [DOI] [PubMed] [Google Scholar]
  4. Brinster R. L., Chen H. Y., Trumbauer M. E., Yagle M. K., Palmiter R. D. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4438–4442. doi: 10.1073/pnas.82.13.4438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Côté F., Collard J. F., Julien J. P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell. 1993 Apr 9;73(1):35–46. doi: 10.1016/0092-8674(93)90158-m. [DOI] [PubMed] [Google Scholar]
  6. Dreyer E. B., Kaiser P. K., Offermann J. T., Lipton S. A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 1990 Apr 20;248(4953):364–367. doi: 10.1126/science.2326646. [DOI] [PubMed] [Google Scholar]
  7. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 1993 May;33(5):429–436. doi: 10.1002/ana.410330502. [DOI] [PubMed] [Google Scholar]
  8. Epstein L. G., Sharer L. R., Oleske J. M., Connor E. M., Goudsmit J., Bagdon L., Robert-Guroff M., Koenigsberger M. R. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics. 1986 Oct;78(4):678–687. [PubMed] [Google Scholar]
  9. Everall I. P., Luthert P. J., Lantos P. L. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry. 1993 May;56(5):481–486. doi: 10.1136/jnnp.56.5.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guy C. T., Cardiff R. D., Muller W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992 Mar;12(3):954–961. doi: 10.1128/mcb.12.3.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hollander H., Levy J. A. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med. 1987 May;106(5):692–695. doi: 10.7326/0003-4819-106-5-692. [DOI] [PubMed] [Google Scholar]
  12. Julien J. P., Meyer D., Flavell D., Hurst J., Grosveld F. Cloning and developmental expression of the murine neurofilament gene family. Brain Res. 1986 Dec;387(3):243–250. doi: 10.1016/0169-328x(86)90030-6. [DOI] [PubMed] [Google Scholar]
  13. Julien J. P., Tretjakoff I., Beaudet L., Peterson A. Expression and assembly of a human neurofilament protein in transgenic mice provide a novel neuronal marking system. Genes Dev. 1987 Dec;1(10):1085–1095. doi: 10.1101/gad.1.10.1085. [DOI] [PubMed] [Google Scholar]
  14. Ketzler S., Weis S., Haug H., Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 1990;80(1):92–94. doi: 10.1007/BF00294228. [DOI] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Lee M. R., Ho D. D., Gurney M. E. Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science. 1987 Aug 28;237(4818):1047–1051. doi: 10.1126/science.3039662. [DOI] [PubMed] [Google Scholar]
  17. Lipton S. A. HIV-related neurotoxicity. Brain Pathol. 1991 Apr;1(3):193–199. doi: 10.1111/j.1750-3639.1991.tb00659.x. [DOI] [PubMed] [Google Scholar]
  18. Masliah E., Ge N., Achim C. L., Hansen L. A., Wiley C. A. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol. 1992 Nov;51(6):585–593. doi: 10.1097/00005072-199211000-00003. [DOI] [PubMed] [Google Scholar]
  19. Masliah E., Ge N., Morey M., DeTeresa R., Terry R. D., Wiley C. A. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest. 1992 Mar;66(3):285–291. [PubMed] [Google Scholar]
  20. Navia B. A., Cho E. S., Petito C. K., Price R. W. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986 Jun;19(6):525–535. doi: 10.1002/ana.410190603. [DOI] [PubMed] [Google Scholar]
  21. Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun;19(6):517–524. doi: 10.1002/ana.410190602. [DOI] [PubMed] [Google Scholar]
  22. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 5;239(4840):586–592. doi: 10.1126/science.3277272. [DOI] [PubMed] [Google Scholar]
  23. Rosenblum M. K. Infection of the central nervous system by the human immunodeficiency virus type 1. Morphology and relation to syndromes of progressive encephalopathy and myelopathy in patients with AIDS. Pathol Annu. 1990;25(Pt 1):117–169. [PubMed] [Google Scholar]
  24. Savio T., Levi G. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res. 1993 Feb 15;34(3):265–272. doi: 10.1002/jnr.490340303. [DOI] [PubMed] [Google Scholar]
  25. Shen Y. M., Hirschhorn R. R., Mercer W. E., Surmacz E., Tsutsui Y., Soprano K. J., Baserga R. Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. Mol Cell Biol. 1982 Sep;2(9):1145–1154. doi: 10.1128/mcb.2.9.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Skowronski J. Expression of a human immunodeficiency virus type 1 long terminal repeat/simian virus 40 early region fusion gene in transgenic mice. J Virol. 1991 Feb;65(2):754–762. doi: 10.1128/jvi.65.2.754-762.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stein B. S., Engleman E. G. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem. 1990 Feb 15;265(5):2640–2649. [PubMed] [Google Scholar]
  28. Sweetnam P. M., Saab O. H., Wroblewski J. T., Price C. H., Karbon E. W., Ferkany J. W. The envelope glycoprotein of HIV-1 alters NMDA receptor function. Eur J Neurosci. 1993 Mar 1;5(3):276–283. doi: 10.1111/j.1460-9568.1993.tb00494.x. [DOI] [PubMed] [Google Scholar]
  29. Thomas F. P., Chalk C., Lalonde R., Robitaille Y., Jolicoeur P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol. 1994 Nov;68(11):7099–7107. doi: 10.1128/jvi.68.11.7099-7107.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994 Jan 13;367(6459):188–193. doi: 10.1038/367188a0. [DOI] [PubMed] [Google Scholar]
  31. Villa G., Monteleone D., Marra C., Bartoli A., Antinori A., Pallavicini F., Tamburrini E., Izzi I. Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients. J Neurol Neurosurg Psychiatry. 1993 Aug;56(8):878–884. doi: 10.1136/jnnp.56.8.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Weis S., Haug H., Budka H. Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol Appl Neurobiol. 1993 Aug;19(4):329–335. doi: 10.1111/j.1365-2990.1993.tb00448.x. [DOI] [PubMed] [Google Scholar]
  33. Weis S., Haug H., Budka H. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol. 1993;85(2):185–189. doi: 10.1007/BF00227766. [DOI] [PubMed] [Google Scholar]
  34. Wiley C. A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann Neurol. 1991 Jun;29(6):651–657. doi: 10.1002/ana.410290613. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES